Cat. #151569
Anti-TFF1 [PS2GE2]
Cat. #: 151569
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-5 days
Target: Trefoil factor 1 (TFF1), also known as pS2
Class: Monoclonal
Application: FACS ; IHC ; IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-TFF1 [PS2GE2]
- Alternate name: BCEI, Breast Cancer Estrogen Inducible Protein, Gastrointestinal Trefoil Protein, Gastrointestinal trefoil protein pS2, HP1A, HPS2, pNR2, TFF1, Trefoil Factor 1Human Entrez Gene ID 731 Human SwissProt P4155 Human Unigene 16287 Human Gene Symbol TFF1Human Chromosome Location 16p11.2
- Clone: PS2GE2
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 6.5 kDa
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; IF ; IP ; WB
- Description: pS2 is a cysteine-rich, 6.5kDa protein found in both oestrogen-dependent (breast tumours) and oestrogen-independent tissues (normal stomach mucosa). About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localisation to the Golgi apparatus. pS2 is primarily expressed in oestrogen receptor-positive breast tumours.
- Immunogen: A synthetic peptide of 28 amino acid residues from the C-terminus of human pS2 protein
- Isotype: IgG1 kappa
- Recommended controls: Normal stomach, breast or ovarian carcinoma
Target Details
- Target: Trefoil factor 1 (TFF1), also known as pS2
- Molecular weight: 6.5 kDa
- Tissue cell line specificity: Normal stomach, breast or ovarian carcinoma
- Target background: pS2 is a cysteine-rich, 6.5kDa protein found in both oestrogen-dependent (breast tumours) and oestrogen-independent tissues (normal stomach mucosa). About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localisation to the Golgi apparatus. pS2 is primarily expressed in oestrogen receptor-positive breast tumours.
Applications
- Application: FACS ; IHC ; IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Williams R, et al. 1996. Hum Pathol.(12):1259-66.PMID: 8958295
